Form submitted successfully. Thank you!

You may download the posters below.

Please visit other areas of our site to learn how our next-generation sequencing solutions can take your immuno-oncology research to the next level.


Immuno-oncology therapies are considered to be promising anti-cancer treatments, generating excitement and hope among researchers, clinicians and patients. The Ion Torrent portfolio of immuno-oncology assays uses the sensitivity of next-generation sequencing (NGS) to help researchers decipher the cancer-immunity cycle within precious samples.


Studies aimed at leveraging an individual’s own immune system as a potential strategy toward the advancement of precision oncology has been a shared goal of scientists for many years. However, the complexities of tumor–immune interactions warrant a multidimensional approach to facilitate well-designed translational research studies and interpretation of results. Genomic analysis solutions based on next-generation sequencing (NGS) can be powerful tools to help gain significant insights in translational and clinical research.